Caroline Rick
Affiliations: | University of Birmingham (United Kingdom) |
Google:
"Caroline Rick"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gray R, Patel S, Ives N, et al. (2021) Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial. Jama Neurology |
| Scobie S, Jowett S, Lambe T, et al. (2021) Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial. Pilot and Feasibility Studies. 7: 154 |
| McIntosh E, Kent S, Gray A, et al. (2021) Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Sackley CM, Rick C, Au P, et al. (2020) A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial. Trials. 21: 436 |
| Herd CP, Tomlinson CL, Rick C, et al. (2018) Botulinum toxins for the prevention of migraine in adults. The Cochrane Database of Systematic Reviews. 6: CD011616 |
| Sackley CM, Smith CH, Rick CE, et al. (2018) Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot). Pilot and Feasibility Studies. 4: 30 |
| Markey KA, Ottridge R, Mitchell JL, et al. (2017) Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial. Jmir Research Protocols. 6: e181 |
| Masterson-Algar P, Burton CR, Brady MC, et al. (2017) The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease. Trials. 18: 397 |
| Clarke CE, Patel S, Ives N, et al. (2016) Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB). Health Technology Assessment (Winchester, England). 20: 1-96 |
| Mathers J, Rick C, Jenkinson C, et al. (2016) Patients' experiences of deep brain stimulation for Parkinson's disease: a qualitative systematic review and synthesis. Bmj Open. 6: e011525 |